Sort   by:  
 Page size 
UnknownDevelopment of thyroglobulin antibodies after GVAX immunotherapy is associated with prolonged survival.
Not available
S-EPMC4199892 | biostudies-literature
TranscriptomicsNovel Immunotherapy-Induced Tertiary Lymphoid Aggregates Accumulate as Intratumoral Nodal Structures of Immune Regulation in Pancreatic Cancer
Immunotherapy provides an alternative approach for cancer treatment. However, in-depth analyses of the effects of immunotherapy on the tumor microenvironment (TME) have not been conducted in non-melanoma tumors. Here we describe changes in the pancreatic ductal adenocarcinoma (PDAC) TME following i...
ORGANISM(S): Homo sapiens 
2014-08-05 | E-GEOD-52171 | biostudies-arrayexpress
UnknownSafety and survival with GVAX pancreas prime and Listeria Monocytogenes-expressing mesothelin (CRS-207) boost vaccines for metastatic pancreatic cancer.
Not available
S-EPMC4397277 | biostudies-literature
GenomicsA Phase II study: CRS207/GVAX plus anti-PD1 and anti-CTLA4 recruits mesothelin- and KRAS-specific T cells into PDAC
A Phase II study: CRS207/GVAX plus anti-PD1 and anti-CTLA4 recruits mesothelin- and KRAS-specific T cells into PDAC
PRJNA1168195 | ENA
GenomicsA Phase II study: CRS207/GVAX plus anti-PD1 and anti-CTLA4 recruits mesothelin- and KRAS-specific T cells into PDAC
A Phase II study: CRS207/GVAX plus anti-PD1 and anti-CTLA4 recruits mesothelin- and KRAS-specific T cells into PDAC
PRJNA1168194 | ENA
UnknownA phase 2 study of GVAX colon vaccine with cyclophosphamide and pembrolizumab in patients with mismatch repair proficient advanced colorectal cancer.
Not available
S-EPMC7013064 | biostudies-literature
UnknownSafety and immunologic correlates of Melanoma GVAX, a GM-CSF secreting allogeneic melanoma cell vaccine administered in the adjuvant setting.
Not available
S-EPMC4491237 | biostudies-literature
UnknownMyeloid derived suppressor and dendritic cell subsets are related to clinical outcome in prostate cancer patients treated with prostate GVAX and ipilimumab.
Not available
S-EPMC4507359 | biostudies-literature
UnknownA Phase II Study of Allogeneic GM-CSF-Transfected Pancreatic Tumor Vaccine (GVAX) with Ipilimumab as Maintenance Treatment for Metastatic Pancreatic Cancer.
Not available
S-EPMC7541669 | biostudies-literature
UnknownA randomized phase II study: CRS207/GVAX plus anti-PD1 and anti-CTLA4 recruits mesothelin- and mKRAS-specific T cells into PDAC.
Not available
S-EPMC12869358 | biostudies-literature
Sort   by:  
 Page size